Alderley Edge, United Kingdom – As a result of expanding business and a desire to better serve its European client base, Pennside Partners today announced the opening of a new office in Alderley Edge, UK, 25 KM south of Manchester. The office is located within the BioHub at Alderley Park, Alderley Edge, W1U 7EU, United Kingdom (http://www.biocity.co.uk/biocity/alderley-park).
“Our new UK location, combined with our Zurich, Switzerland site, will enable us to expand our delivery of high-quality, actionable business insights and competitive intelligence services to our pharmaceutical, biotechnology, and medical device clients throughout the EU,” said Michael Rhoads, President and Partner of Pennside Partners.
He added: “Alderley Park is an ideal area for our new UK office given its proximity to local pharma and biotech companies, as well as access to an exceptional talent pool of potential employees.”
Thomas Penrice, Vice President, Partner, and EU Managing Director will oversee the new UK office.
For more information, including how Pennside can help with your business development and competitive intelligence needs, contact Pennside Partners at +44 (0) 20 3695 7639 or firstname.lastname@example.org. You can also visit the company website: www.pennside.com.
About Pennside Partners
Pennside Partners is a leading business development consulting firm that has been serving the global pharmaceutical, biotechnology, and medical device sectors or more than 25 years. We earn our clients’ trust by consistently delivering high-quality, actionable business insights and competitive intelligence. Our clients gain significant competitive advantages, including knowledge we acquire from mining the industry's deepest analog repository containing unmatched data insights into major launches. We offer an expert worldwide team of industry professionals who support our clients by formulating best-in-class tactical and strategic analysis. Pennside has offices In Wyomissing, PA, USA, Alderley Edge, UK, and Zurich, Switzerland.